v3.26.1
Investments (Tables)
12 Months Ended
Dec. 31, 2025
Investments  
Schedule of investments

​

​

​

​

​

​

​

​

December 31, 

​

  ​ ​ ​

2024

  ​ ​ ​

2025

​

​

US$

​

US$

​

​

​

​

​

Equity investments accounted for using the equity method (i)

 

336,704

 

374,999

Equity investments with readily determinable fair values (ii)

 

3,838

 

23,315

Equity investments without readily determinable fair values (iii)

 

149,343

 

129,358

Available-for-sale debt investments (iv)

 

40,800

 

24,130

​

​

​

​

​

Total

 

530,685

 

551,802

(i)

Investments have been accounted for under the equity method where the Group has significant influence over these investees and the investments are considered as in-substance common shares.

(ii)

The Group does not have the ability to exercise significant influence over these investments. Therefore, it has been precluded from applying the equity method of accounting.

(iii)

Equity securities without readily determinable fair values and over which the Company has neither significant influence nor control through investments in common stock or in-substance common stock.

(iv)

Available-for-sale debt investments are convertible debt instruments issued by private companies and investments in preferred shares that are redeemable at the Group’s option, which are measured at fair value as disclosed in Note 29(a).

Schedule of equity method investments

​

​

​

​

​

​

​

​

December 31, 

​

  ​ ​ ​

2024

  ​ ​ ​

2025

​

 

US$

 

US$

​

​

​

​

​

Current assets

​

480,890

​

765,996

Non-current assets

 

1,276,950

 

2,119,515

Current liabilities

 

55,971

 

72,495

Non-current liabilities

 

12,968

 

106,961

​

​

​

​

​

​

​

​

​

​

For the year ended December 31,

​

​

2023

​

2024

​

2025

​

  ​ ​ ​

US$

  ​ ​ ​

US$

  ​ ​ ​

US$

​

​

​

​

​

​

​

Revenues

 

147,015

 

54,743

​

573,021

Gross profit

 

102,095

 

4,885

​

431,241

Net (loss) income

 

8,893

 

(59,519)

​

402,227

Net (loss) income attributable to the investees

 

8,893

 

(59,519)

​

402,227

Schedule of available-for-sale debt investments

​

​

​

​

​

​

​

​

​

​

​

​

For the year ended December 31, 2024

​

​

Cost or

​

Gross

​

Translation

​

Balance

​

​

amortized cost

​

unrealized losses

​

difference

​

as of year end

​

  ​ ​ ​

US$

  ​ ​ ​

US$

  ​ ​ ​

US$

  ​ ​ ​

US$

Available-for-sale debt investments

 

63,928

 

(23,108)

 

(20)

 

40,800

​

​

​

​

​

​

​

​

​

​

​

​

For the year ended December 31, 2025

​

​

Cost or

​

Gross

​

Translation

​

Balance

​

​

amortized cost

​

unrealized losses

​

difference

​

as of year end

​

  ​ ​ ​

US$

  ​ ​ ​

US$

  ​ ​ ​

US$

  ​ ​ ​

US$

Available-for-sale debt investments

 

40,800

 

(16,684)

 

14

 

24,130

​